- $8.86bn
- $16.51bn
- $8.28bn
- 82
- 89
- 33
- 76
C2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 6,491 | 4,435 | 7,985 | 11,075 | 8,279 |
Cost of Revenue | |||||
Gross Profit | 4,902 | 2,951 | 5,164 | 7,855 | 6,101 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 9,131 | 8,689 | 5,560 | 4,906 | 4,980 |
Operating Profit | -2,640 | -4,254 | 2,425 | 6,169 | 3,299 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -3,008 | -4,840 | 1,891 | 5,734 | 2,883 |
Provision for Income Taxes | |||||
Net Income After Taxes | -3,682 | -4,904 | 1,313 | 4,082 | 3,207 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -3,553 | -4,860 | 973 | 3,674 | 2,855 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -3,553 | -4,860 | 973 | 3,674 | 2,855 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -3.13 | -5.18 | 3.97 | 9.1 | 9.86 |
Dividends per Share |